Association Between Glutathione Peroxidase-1 (GPx-1) Polymorphisms and Schizophrenia in the Chinese Han Population
Authors:
Open Access
- 1 October 2020
- journal article
- research article
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 16, 2297-2305
Abstract
Objective: The dopamine and oxidative stress hypotheses are leading theories of the pathoetiology of schizophrenia (SCZ). Glutathione Peroxidase 1 (GPx-1), a major antioxidant enzyme, and the most abundantly expressed member of the GPx family, plays an important role in metabolic dopamine changes, which are closely related to neurological and psychiatric disorders. The impact of GPx-1 polymorphisms has rarely been explored in the field of SCZ. Here, we explored the possible relationship between GPx-1 gene polymorphisms and SCZ in Chinese Han subjects by using the polymerase chain reaction-restriction fragment length polymorphism method. Methods: DNA from 786 patients (360 patients with schizophrenia and 426 healthy controls) was genotyped for the single-nucleotide polymorphisms rs1800668 C/T and rs1050450 C/T in GPx-1 using polymerase chain reaction-restriction fragment length polymorphism analysis. Analysis of the association between GPx-1 and SCZ was performed using SPSS 22.0, while Haploview 4.2 software and SHEsis software were used to perform linkage disequilibrium analysis and haplotype analysis. Results: The results indicated that the GPx-1 polymorphisms rs1050450 and rs1800668 were associated with SCZ. We found that the C-allele of rs1800668 C/T may be a protection factor against SCZ in general, but in particular, for males. Furthermore, the CT and TC (GPx-1 rs1800668 C/T and rs1050450 C/T) haplotypes may be susceptible to SCZ in the population. Finally, no significant differences in allelic or genotypic frequencies of rs1050450 were detected between cases and controls from whole or stratification analyses by gender. Conclusion: GPx-1 polymorphisms are related to SCZ in Chinese Han subjects. Our results suggested that GPx-1 may be a potential gene that influences SCZ.Keywords
This publication has 69 references indexed in Scilit:
- Elevation of glutathione as a therapeutic strategy in Alzheimer diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative ViewAntioxidants & Redox Signaling, 2011
- Glutathione Peroxidase-1 in Health and Disease: From Molecular Mechanisms to Therapeutic OpportunitiesAntioxidants & Redox Signaling, 2011
- Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patientsBMC Psychiatry, 2011
- Synergy Between Glutathione Peroxidase-1 and Astrocytic Growth Factors Suppresses Free Radical Generation and Protects Dopaminergic Neurons against 6-HydroxydopamineRejuvenation Research, 2011
- The Role of Genetics in the Etiology of SchizophreniaPsychiatric Clinics of North America, 2010
- Genetic variant of glutathione peroxidase 1 in autismBrain and Development, 2010
- Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidenceProceedings of the National Academy of Sciences, 2007
- Shear Stress Enhances Glutathione Peroxidase Expression in Endothelial CellsBiochemical and Biophysical Research Communications, 2000
- Alterations in the distribution of glutathione in the substantia nigra in Parkinson's diseaseJournal of Neural Transmission, 1997